Riccardo Lobefaro

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Body Mass Index

Sentinel Lymph Node

Positive Breast Cancer

Top Venues

Therapeutic advances in medical oncology

Clinical Medicine Insights. Oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica, Mario Scartozzi, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Nicoletta Pella, Francesca Bergamo, Alessandra Raimondi, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Cristina Granetto, Fable Zustovich, Monica Ronzoni, Silvana Leo, Federica Morano, Fotios Loupakis, Federica Buggin, Vittorina Zagonel, Angelo Paolo Dei Tos, Chiara Cremolini, Luca Boni, Filippo Pietrantonio, null null
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by GONO Foundation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Francesca Ligorio, Luca Zambelli, Achille Bottiglieri, Lorenzo Castagnoli, Emma Zattarin, Riccardo Lobefaro, Arianna Ottini, Andrea Vingiani, Serenella M Pupa, Giulia V Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients. Therapeutic advances in medical oncology 13 (2021)
Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, Francesco Pantano, Mario Scartozzi, Cristina Madaudo, Filippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, Bruno Vincenzi, Roberto Moretto, Marco Puzzoni, Silvio Ken Garattini, Riccardo Lobefaro, Giuseppe Tonini, Daniele Santini
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? Clinical Medicine Insights. Oncology 14 (2020)
Emma Zattarin, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, Claudio Vernieri
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications. Cells 9 (12) (2020)
Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, Michele Prisciandaro, Francesca Ligorio, Marta Brambilla, Pierangela Sepe, Francesca Corti, Giorgia Peverelli, Arianna Ottini, Teresa Beninato, Laura Mazzeo, Carmen G Rea, Gabriella Mariani, Filippo de Braud, Giulia V Bianchi, Claudio Vernieri, Giuseppe Capri
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis. Therapeutic advances in medical oncology 12 (2020)
Giuseppe Viscardi, Davide Di Natale, Morena Fasano, Marta Brambilla, Riccardo Lobefaro, Alessandro De Toma, Giulia Galli
Circulating biomarkers in malignant pleural mesothelioma. Exploration of targeted anti-tumor therapy 1 (6) (2020)